EPOR and lung cancer: 56 days after tumor cell injection, shSCR2 tumors were 4 times larger than shEPOR1 and shEPOR2 tumors (p<0.01) (Figure 1B), indicating that the loss of EPOR is associated with reduced tumor growth in A549 lung cancer cells.